Chest Medicine
SR | Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis.
13 Dec, 2022 | 14:15h | UTCInhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis – Cochrane Library
Summary: Inhaling antibiotics to treat lung infection in people with cystic fibrosis – Cochrane Library
Review | Chest wall loading in the ICU: pushes, weights, and positions.
13 Dec, 2022 | 14:14h | UTCChest wall loading in the ICU: pushes, weights, and positions – Annals of Intensive Care
RCT | Twice-daily oral zinc in the treatment of patients with COVID-19.
12 Dec, 2022 | 12:48h | UTC
Review | Parasitic lung diseases.
12 Dec, 2022 | 12:32h | UTCParasitic lung diseases – European Respiratory Review
Cohort Study | Tobacco use and incidence of adverse oral health outcomes.
12 Dec, 2022 | 12:30h | UTCCommentary: Expert reaction to study looking at smoking, vaping and oral health – Science Media Centre
Review | Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism.
12 Dec, 2022 | 12:21h | UTC
M-A | Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure.
9 Dec, 2022 | 13:31h | UTCEditorial: Awake prone positioning and covid-19 – The BMJ
News Release: Lying prone reduces need for breathing tube in covid-19 patients – BMJ Newsroom
Commentary: Study shows prone position limited breathing tubes for COVID-19 patients – CIDRAP
Commentary on Twitter
Lying prone reduces need for breathing tube in #covid patients, but evidence for the effect on death or other outcomes is inconclusive, finds new research in @bmj_latest by @kenparhar and colleagues
📖 ▶️ https://t.co/yodPDxbeuI pic.twitter.com/cHAWx0w00v— BMJ (@bmj_company) December 8, 2022
SR | Efficacy and safety of COVID‐19 vaccines.
8 Dec, 2022 | 13:04h | UTCEfficacy and safety of COVID‐19 vaccines – Cochrane Library
Summary: What are the benefits and risks of vaccines for preventing COVID-19? – Cochrane Library
Commentary: Are COVID-19 vaccines effective and safe? New Cochrane evidence – Evidently Cochrane
M-A | Physical and psychological impairment in survivors of acute respiratory distress syndrome.
8 Dec, 2022 | 12:35h | UTC
FDA | No useful monoclonal antibody treatments left against new COVID-19 variants.
7 Dec, 2022 | 14:31h | UTCFDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants – HealthDay
Related: Study shows Omicron sublineage BQ.1.1 is resistant to all monoclonal antibodies.
M-A | Efficacy of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in asthma.
7 Dec, 2022 | 14:26h | UTC
Policy Statement | Palliative care early in the care continuum among patients with serious respiratory illness.
7 Dec, 2022 | 14:22h | UTC
Commentary on Twitter
Read "Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness: An Official ATS/AAHPM/HPNA/SWHPN Policy Statement" here: https://t.co/vMALIcwp3K pic.twitter.com/lUclouz0Dj
— American Thoracic (@atscommunity) September 26, 2022
SR | Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation.
7 Dec, 2022 | 14:11h | UTC
SR | Non‐invasive positive pressure ventilation for central sleep apnea in adults.
7 Dec, 2022 | 14:09h | UTCNon‐invasive positive pressure ventilation for central sleep apnoea in adults – Cochrane Library
Summary: Non-invasive ventilation for people with central sleep apnoea – Cochrane Library
M-A | Higher vs. lower dose corticosteroids for severe to critical COVID-19.
6 Dec, 2022 | 14:00h | UTC
Cross-sectional study | Overweight women may be at increased risk of long Covid.
2 Dec, 2022 | 14:33h | UTCCommentaries:
Overweight women may be at highest risk of long COVID – new research – The Conversation
Cohort Study | Tobacco smoking and risks of more than 470 diseases in China.
2 Dec, 2022 | 14:14h | UTCCommentary: Smoking increases the risks of 56 diseases in Chinese adults – Oxford University
M-A | Efficacy and safety of COVID-19 inactivated vaccine.
1 Dec, 2022 | 14:00h | UTCEfficacy and safety of COVID-19 inactivated vaccine: A meta-analysis – Frontiers in Medicine
Collection of Cochrane evidence on diagnosing tuberculosis.
1 Dec, 2022 | 13:56h | UTCCollection of Cochrane evidence on diagnosing tuberculosis – Cochrane Library
RCT | Medical masks vs. N95 respirators for preventing COVID-19 among health care workers.
30 Nov, 2022 | 13:52h | UTC
Commentary on Twitter
A randomized trial of medical masks vs N95s in health care workers to prevent Covid https://t.co/CSJkFLE15z
—It's woefully underpowered but ruled out a doubling of hazard for use of medical masks
—In 3 of the 4 countries there was less risk with N95s (p=NS) pic.twitter.com/B7iBvT1J9B— Eric Topol (@EricTopol) November 28, 2022
ACP Guidance | Outpatient treatment of confirmed COVID-19.
30 Nov, 2022 | 13:54h | UTCCommentary: New ACP living practice points, mortality data on COVID-19 – ACP Internist
Cohort Study | Acute and postacute sequelae associated with SARS-CoV-2 reinfection.
30 Nov, 2022 | 13:42h | UTCAcute and postacute sequelae associated with SARS-CoV-2 reinfection – Nature Medicine
News Release: Repeat COVID-19 infections increase risk of organ failure, death – Washington University School of Medicine
Commentary: SARS-CoV-2 Reinfection Ups Risks for Death, Hospitalization – HealthDay
Cohort Study | Impact of BMI on outcomes in respiratory ECMO.
30 Nov, 2022 | 13:35h | UTCImpact of BMI on outcomes in respiratory ECMO: an ELSO registry study – Intensive Care Medicine
WHO Global tuberculosis report 2022.
29 Nov, 2022 | 14:25h | UTCGlobal tuberculosis report 2022 – World Health Organization
News Release: Tuberculosis deaths and disease increase during the COVID-19 pandemic – World Health Organization
Video Summary: WHO Global Tuberculosis Report 2022: Key findings and messages – World Health Organization
Commentary on Twitter (thread – click for more)
🆕 WHO 2022 Global TB report 🧵
For the first time in many years, an increase has been reported in the number of people falling ill with #tuberculosis (TB) and drug-resistant TB.
📌 https://t.co/AvVFJ6j1E5 pic.twitter.com/dPywHXZ6ND
— World Health Organization (WHO) (@WHO) October 27, 2022
Study shows Omicron sublineage BQ.1.1 is resistant to all monoclonal antibodies.
29 Nov, 2022 | 14:16h | UTCOmicron sublineage BQ.1.1 resistance to monoclonal antibodies – The Lancet Infectious Diseases
Commentaries:
Omicron variant BQ.1.1 found to be resistant to all monoclonal antibody treatments – MedicalXpress
Related: BQ.1 and BQ.1.1 are now the dominant COVID variants. What does that mean? – MedicalXpress
Commentary on Twitter
The BQ.1.1 variant, as compared with many of the other new variants, is resistant to all clinically used monoclonal antibodies.
BQ.1/BQ.1.1 are now the dominant variants in the United Stateshttps://t.co/PCFPSGF2uy @TheLancetInfDis pic.twitter.com/dHucxoGokC— Eric Topol (@EricTopol) November 19, 2022